• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORGANON & CO. JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Insufficient Information (4580)
Event Date 01/01/2022
Event Type  Injury  
Manufacturer Narrative
Based on the information we have received, there is no indication that the device malfunctioned.The device is assembled according to specifications.In process and finished product testing are performed and approved prior to release.
 
Event Description
As a result, the jada system did not work properly.The patient continued bleeding and had to undergo a hysterectomy [device ineffective].Provider admitted that provider did not know how to use the jada system.Caller states that provider filled fluid into the wrong chamber [wrong technique in device usage process].Case narrative: this spontaneous report was received from a physician via company representative referring to a female patient of unknown age.The patient gave birth at 34 weeks gestation and had pre-eclampsia.The patient's concurrent conditions included uterine atony.The patient's concomitant medications, and drug reactions/allergies were not reported.This report concerns 1 patient and 1 device.On an unknown date in 2022 (reported as "a few months ago"), the patient was started on vacuum-induced hemorrhage control system (jada system) via an unknown route for abnormal postpartum bleeding (postpartum bleeding) (lot# and expiration date were not reported).It was reported that the physician (also reported as "provider") admitted that the physician did not know how to use the vacuum-induced hemorrhage control system (jada system).On an unknown date in 2022 (reported as "a few months ago"), the physician "filled fluid into the wrong chamber" (wrong technique in device usage process).As a result, the vacuum-induced hemorrhage control system (jada system) did not work properly.The patient continued bleeding and had to undergo a hysterectomy (device ineffective).It was also reported that the patient did not die.No additional adverse event (ae) or product quality complaint (pqc) were identified.No additional information was known at the time of reporting.The availability of vacuum-induced hemorrhage control system (jada system) was unknown.For vacuum-induced hemorrhage control system (jada system), lot number and serial number were not available.Upon internal review, the event of "device ineffective" was determined to be serious as it required intervention.Medical device reporting criteria: serious injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer (Section G)
ORGANON & CO.
30 hudson street
jersey city NJ 07302
Manufacturer Contact
30 hudson street
jersey city, NJ 07302
MDR Report Key15853499
MDR Text Key304205221
Report Number3002806821-2022-00008
Device Sequence Number1
Product Code OQY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
510K K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
-
-